Relief Therapeutics is a Swiss biopharmaceutical company based in Geneva. The company focuses on developing drugs for serious diseases with few or no existing treatment options. Its lead compound, RLF-100, is a synthetic form of a natural peptide that protects the lung. The company was incorporated as Relief Therapeutics Holdings AG (RFLB.S) and listed on the SIX Swiss Exchange in 2016.
Attributes | Values |
---|---|
rdf:type | |
rdfs:label |
|
rdfs:comment |
|
foaf:name |
|
foaf:homepage | |
name |
|
foaf:depiction | |
location | |
dcterms:subject | |
Wikipage page ID |
|
Wikipage revision ID |
|
Link from a Wikipage to another Wikipage |
|
Link from a Wikipage to an external page | |
sameAs | |
dbp:wikiPageUsesTemplate | |
thumbnail | |
foundation |
|
homepage | |
industry | |
key people |
|
location | |
logo |
|
products |
|
type | |
has abstract |
|
prov:wasDerivedFrom | |
page length (characters) of wiki page |
|
founding year |
|
industry | |
product | |
type | |
foaf:isPrimaryTopicOf | |
is Link from a Wikipage to another Wikipage of | |
is successor of | |
is successor of | |
is foaf:primaryTopic of |